Read + Share
Amedeo Smart
Independent Medical Education
Mao L, Xiao Y, Yang QC, Yang SC, et al. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells. Oral Oncol 2021;121:105472.PMID: 34333450
Email
LinkedIn
Facebook
Twitter
Privacy Policy